- Ayr began with only two markets in 2019: Nevada and Massachusetts.
- Since then, the company has entered five new markets through acquisitions, including the recent deal to buy Liberty Health in Florida.
- Using its public shares as currency, Ayr is executing on a consolidation strategy that is aided by the regulatory reality that limits one license per operator in most markets.
- The stock is a reasonable buy given its inexpensive valuation and pending acquisitions that will add significant scale and market access in 2021.
For further details see:
Ayr Strategies: This Upstart Consolidator Will Keep Growing